Prospective comparative study between two first-line regimens for Helicobacter pylori eradication: Non-bismuth quadruple versus bismuth quadruple therapy

Management of <i>Helicobacter pylori</i> infection—the Maastricht V/Florence Consensus Report

Peter Malfertheiner, Françis Mégraud, Colm O’Morain et al. · Gut · 2016 · 2.9K citations · Full text

Medicine, Infectious Diseases, Microbiology +13

ACG Clinical Guideline: Treatment of Helicobacter pylori Infection

William D. Chey, Grigorios I. Leontiadis, Colin W. Howden et al. · The American Journal of Gastroenterology · 2017 · 1.6K citations

Pharmacy, Infectious Diseases, Pharmacotherapy +15

<i>Helicobacter pylori</i> resistance to antibiotics in Europe and its relationship to antibiotic consumption

Françis Mégraud, Samuel Coenen, Ann Versporten et al. · Gut · 2012 · 832 citations

Life Sciences, Microbiology, Pharmacology +14

Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial

Peter Malfertheiner, Franco Bazzoli, Jean‐Charles Delchier et al. · The Lancet · 2011 · 516 citations

Pharmacy, Pharmacology, Pharmacotherapy +11

Optimized Nonbismuth Quadruple Therapies Cure Most Patients With Helicobacter pylori Infection in Populations With High Rates of Antibiotic Resistance

Javier Molina‐Infante, Marco Romano, Miguel Fernández‐Bermejo et al. · Gastroenterology · 2013 · 197 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +9